The landscape of dementia diagnosis has advanced drastically with the arrival of subtle biomarkers, which includes amyloid PET scans, tau imaging, and blood-based mostly checks that may detect Alzheimer's pathology many years right before signs or symptoms arise. Even though these technological advances depict exceptional progress in comprehension